Cytoplasmic polyadenylation element-binding protein 4 is highly expressed in human glioma

Hongchao Hu1, Lulu Cong, Chaohui Liang

  • 1aDepartment of Neurosurgery, The Second Hospital of Hebei Medical University, Hebei bDepartment of Neurosurgery, Handan Central Hospital, Handan, China.

Neuroreport
|April 21, 2016
PubMed

Insights

Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) is overexpressed in gliomas and correlates with higher pathological grades. This suggests CPEB4 may contribute to glioma development and progression.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cytoplasmic polyadenylation element-binding proteins (CPEBs) are involved in tumor growth and vascularization.
  • CPEB4 overexpression is linked to poor prognoses in pancreatic cancer.
  • The role of CPEB4 in glioma tumorigenesis remains unexplored.

Purpose of the Study:

  • To investigate the expression and potential role of CPEB4 in glioma pathogenesis.
  • To analyze the correlation between CPEB4 expression and glioma pathological grade.

Main Methods:

  • Analysis of CPEB4 mRNA and protein expression in normal brain tissues and gliomas.
  • Utilized immunohistochemistry, real-time PCR, and western blotting.
  • Compared CPEB4 expression in U87 and U251 glioma cell lines.

Main Results:

  • CPEB4 expression was significantly higher in gliomas compared to normal brain tissues.
  • CPEB4 expression positively correlated with advanced pathological grades of glioma.
  • CPEB4 was predominantly localized in the cytoplasm and showed differential expression in glioma cell lines.

Conclusions:

  • CPEB4 is upregulated in gliomas and associated with tumor grade.
  • CPEB4 may play a role in the development and progression of gliomas.
  • Further research into CPEB4's function in glioma is warranted.

Related Concept Videos